Llovet JM - Search Results

1

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.

Martin-Serrano MA, Kepecs B, Torres-Martin M, Bramel ER, Haber PK, Merritt E, Rialdi A, Param NJ, Maeda M, Lindblad KE, Carter JK, Barcena-Varela M, Mazzaferro V, Schwartz M, Affo S, Schwabe RF, Villanueva A, Guccione E, Friedman SL, Lujambio A, Tocheva A, Llovet JM, Thung SN, Tsankov AM, Sia D. Martin-Serrano MA, et al. Among authors: llovet jm. Gut. 2023 Apr;72(4):736-748. doi: 10.1136/gutjnl-2021-326514. Epub 2022 May 18. Gut. 2023. PMID: 35584893 Free PMC article.

2

Resection and liver transplantation for hepatocellular carcinoma.

Llovet JM, Schwartz M, Mazzaferro V. Llovet JM, et al. Semin Liver Dis. 2005;25(2):181-200. doi: 10.1055/s-2005-871198. Semin Liver Dis. 2005. PMID: 15918147 Review.

3

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

Schwartz M, Roayaie S, Llovet J. Schwartz M, et al. J Hepatol. 2005 Oct;43(4):584-9. doi: 10.1016/j.jhep.2005.07.019. J Hepatol. 2005. PMID: 16120468 Review. No abstract available.

4

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

Lopez PM, Villanueva A, Llovet JM. Lopez PM, et al. Among authors: llovet jm. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1535-47. doi: 10.1111/j.1365-2036.2006.02932.x. Aliment Pharmacol Ther. 2006. PMID: 16696801 Free article. Review.

5

Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.

Llovet JM, Schwartz M, Fuster J, Bruix J. Llovet JM, et al. Semin Liver Dis. 2006 Aug;26(3):248-53. doi: 10.1055/s-2006-947296. Semin Liver Dis. 2006. PMID: 16850374

6

Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.

Lemmer ER, Friedman SL, Llovet JM. Lemmer ER, et al. Among authors: llovet jm. Semin Liver Dis. 2006 Nov;26(4):373-84. doi: 10.1055/s-2006-951604. Semin Liver Dis. 2006. PMID: 17051451 Review.

7

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. Llovet JM, et al. Gastroenterology. 2006 Dec;131(6):1758-67. doi: 10.1053/j.gastro.2006.09.014. Epub 2006 Sep 19. Gastroenterology. 2006. PMID: 17087938

8

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.

Lopez PM, Villanueva A, Roayaie S, Llovet JM. Lopez PM, et al. Among authors: llovet jm. Liver Transpl. 2006 Dec;12(12):1747-54. doi: 10.1002/lt.21018. Liver Transpl. 2006. PMID: 17133591 Free article. Review. No abstract available.

9

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL. Kremer-Tal S, et al. Among authors: llovet jm. J Hepatol. 2007 Apr;46(4):645-54. doi: 10.1016/j.jhep.2006.10.012. Epub 2006 Nov 27. J Hepatol. 2007. PMID: 17196295 Free PMC article.

10

Genomics and signaling pathways in hepatocellular carcinoma.

Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Villanueva A, et al. Among authors: llovet jm. Semin Liver Dis. 2007 Feb;27(1):55-76. doi: 10.1055/s-2006-960171. Semin Liver Dis. 2007. PMID: 17295177 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page